Introduction {#S0001}
============

The leishmaniases are a spectrum of diseases of humans and other mammals that are endemic in 88 countries with an estimated yearly incidence of l--1.5 million cases of cutaneous leishmaniasis and 500000 cases of visceral leishmaniasis ([@CIT0001]). Cutaneous and visceral leishmaniases are endemic in Iran ([@CIT0002], [@CIT0003]). Different species of *Leishmania (L.)* parasites are causative agent of these diseases in Iran ([@CIT0004]--[@CIT0006]). *Leishmania* species differ from each other from many aspects including clinical presentation of the disease, their vectors and reservoirs, and their epidemiological criteria. Hence, identification of *Leishmania* species is important in *Leishmania* studies including clinical research, evaluation of vaccines and drugs, epidemiology, prevention and control of the diseases ([@CIT0007]).

Different methods are used for species identification of *Leishmania* parasites including: use of monoclonal antibodies ([@CIT0006]), study of isoenzyme ([@CIT0008]), and molecular methods ([@CIT0009]). Not all clinical and experimental laboratories have sufficient facilities necessary for identification of *Leishmania* parasites at species level. Laboratories lacking such facilities usually use *Leishmania* species that have already been identified by other laboratories. Hence, exchange of *Leishmania* parasites with identified species between different laboratories takes place usually. It is possible that *Leishmania* isolates are mixed up or they are contaminated with non-*Leishmania* trypanosomatids (e.g. *Crithidia*) in laboratory. Mixing up or contamination of *Leishmania* isolates in one laboratory and exchange of this parasite between laboratories can lead to incorrect data and conclusions. This pitfall can be prevented by verification of *Leishmania* isolates of uncertain identity. The gold standard for species identification is still isoenzyme electrophoresis ([@CIT0010]). However, only specialized laboratories have sufficient facilities and expertise to perform this method. The internal transcribed spacer 1 (ITS1) sequencing is an alternative method for species identification that does not have many technical drawbacks of the isoenzyme electrophoresis.

The aim of this study was to evaluate the relative feasibility of ITS1 sequencing, in comparison to isoenzyme electrophoresis for verification of *Leishmania* species.

Material and Methods {#S0002}
====================

Parasite {#S20003}
--------

Six *Leishmania* isolates were received as gifts from different research laboratories (see [Table 1](#T0001){ref-type="table"}). The species of these isolates were assumed to be known based on isoenzyme profile provided by the donating laboratories. The isolates were stored in liquid nitrogen and were recovered for the present study by thawing and culturing them in NNN media ([@CIT0011]). Logarithmic parasites were harvested and washed by phosphate buffer saline (PBS) two times and were stored in aliquots of 100×10^6^ parasites (for DNA extraction) and 1×10^9^ parasites (for isoenzyme electrophoresis) in −70°C.

###### 

*Leishmania* isolates studied in the present study

  Isolate No.   International code    Assumed species according to the donating institutions   Real species as identified in the present study
  ------------- --------------------- -------------------------------------------------------- -------------------------------------------------
  1             MHOM/IR/75/ER         *L. major*^[a](#TF0001){ref-type="table-fn"}^            *L. major*
  2             MHOM/IR/05/SHZ5       *L. infantum*                                            *C. fasciculata*
  3             MCAN/IR/97/LON 49     *L. infantum*                                            *L. tropica*
  4             Not available         *L. infantum*                                            *C. fasciculata*
  5             MHOM/IR/04/IPI-UN10   *L. infantum*                                            *L. infantum*
  6             MHOM/AF/88/KK27       *L. tropica*                                             *L. tropica*

Abbreviations used: *L.; Leishmania, C.; Crithidia*.

Amplification of ITS1 and RFLP analysis {#S20004}
---------------------------------------

Genomic DNA was extracted by LiCl extraction ([@CIT0012]). The ITS1 region was amplified using DNA extracted from parasite and ITS1 specific primers LITSR and L5.8S and analyzed by restriction fragment length polymorphism (RFLP) analysis using the restriction endonuclease *Hae*III ([@CIT0013]).

Sequencing of ITS1 {#S20005}
------------------

PCR amplification of genomic DNA from each of the isolates No. 1, 2, 4, and 5 resulted in a sharp single band in agarose gel electrophoresis. These PCR products were directly sent for sequencing (Macrogene, Seoul, Korea). Each PCR product was sequenced at least twice by ITS1 specific primers: once by the forward primer (LITSR) and once by the reverse primer (L5.8S). Nucleotide in each position was considered correct if the two sequencing results (which were sequenced in opposite directions) confirmed each other. The ITS1 sequences of isolates No. 3 and 6 were determined through a T/A cloning approach. This approach was done because PCR amplification of these isolates did not resulted in a single sharp band in electrophoresis; hence direct sequencing of PCR products were not sufficiently informative and conclusive. The T/A cloning was performed by using InsTA cloning kit (Fermentas, Burlington, Canada) according to the manufacturer instructions. Briefly, ITS1 fragment was amplified through PCR by ITS1 specific primers. The product of ITS1-PCR was run in agarose gel electrophoresis. The band that was compatible to ITS1 molecular weight (about 300 base pairs) was excised and extracted from agarose gel by Silica Bead DNA Gel Extraction kit (Fermentas Co.). Gel extracted DNA fragment was inserted into pTZ57R plasmid by ligase enzyme. The insert containing plasmid was transformed into DH5α strain of Escherichia coli bacteria. The transformed bacteria were cultured overnight and plasmids were purified by a plasmid purification kit (Bioneer Co.) according to the manufacturer instruction. This kit purifies the plasmids by the modified alkaline lysis method. The purified plasmids were sequenced by plasmid specific forward and reverse primers.

Isoenzyme electrophoresis {#S20006}
-------------------------

The isoenzyme study was performed using discontinuous polyacrylamide gel electrophoresis (PAGE) as described earlier ([@CIT0014]). Each *Leishmania* strain was tested for the activity of at least four enzyme systems out of the following enzymes: glucose phosphate isomerase (GPI), malate dehydrogenase (MDH), nucleoside hydrolase (NH), malic enzyme (ME), super oxide dismutase (SOD) and phosphoglucomutase (PGM). Performance of this technique, due to fund limitation, was restricted to the isolates whose species were revealed to be different from the assumed species (i.e. declared by the donating institution) and for the only true *L. infantum* isolate studied in the present study.

Results {#S0007}
=======

RFLP {#S20008}
----

RFLP patterns of isolate No.1 was compatible with *L. major*. RFLP pattern for isolates No 2 and 4 were suggestive of other trypanosomatids such as *Crithidia* species (e.g. *C. fasciulata* with GenBank accession number **Y00055.1**). RFLP patterns for isolates 3, 5 and 6 were compatible with the reported RFLP pattern for *L. tropica* or *L. infantum* (data not shown).

ITS1 sequencing {#S20009}
---------------

The ITS1 of the *Leishmania* isolates studied in the present report (six isolates) were sequenced and deposited in GenBank ([Fig. 1](#F0001){ref-type="fig"}). Comparison of the ITS1 sequences of the six isolates with other *Leishmania* species in GenBank (<http://www.ncbi.nlm.nih.gov/sites/entrez?db=nucleotide>) revealed the following results: isolate 1 was 99% and 100% identical to *L. major* Friedlin strain and *L. major* MRHO/IR/75/ER strain respectively (GenBank accession numbers **[CP000079.1]{.ul}** and **[EF653269.1]{.ul}** respectively), isolate 2 and 4 (these two isolates showed complete identical ITS1 sequences) have 96% identity to *C. fasciculata*(accession number **[Y00055.1]{.ul}**), isolate 3 had 100% identity with many *L. tropica* strains e.g. *L. tropica* with GenBank accession number **[FJ948456.1]{.ul}**, isolate 5 was 100% identical to *L. infantum* MCAN/ES/98/LLM-877 strain (GenBank accession number: **[AM502245.1]{.ul}**), and isolate 6 was 99% identity to *L. tropica* MHOM/SU/60/OD strain (accession number **[EU326226.1]{.ul}**). It was concluded that isolate 1, 2, 3, 4, 5 and 6 were *L. major*, *C. fasciculata*, *L. tropica*, *C. fasciculata*, *L. infantum*, and *L. tropica* respectively (as are shown in [Table 1](#T0001){ref-type="table"}). It is noteworthy that ITS1 sequences of the two *Crithidia* isolates were completely identical. This ITS1 sequence (accession number **[HM004585.1]{.ul}**) has 11 different nucleotides in comparison to its closest match in GenBank (*C. fasciculata* accession number **[Y00055.1]{.ul}**).

![ITS1 containing sequences of *Leishmania* species studied in this study](IJP-6-041-g001){#F0001}

Species identification by isoenzyme electrophoresis {#S20010}
---------------------------------------------------

The isolate No. 3 was revealed *L. tropica* according to ITS1 sequence while it was stated to be *L. infantum* by the donating institution. Isoenzyme electrophoresis, as the gold standard for species identification, was performed for resolving this discrepancy. Characterization of isolate No. 3, using 4 enzyme systems (GPI, MDH, NH, and PGM), with reference strains indicated that its isoenzyme profile in all 4 enzyme systems is compatible with *L. tropica* MHOM/IR/72/NADIM3 strain. The isolate No. 5 was revealed *L. infantum* according to ITS1 sequence and according to data of the donating institution. The isoenzyme electrophoresis was performed for confirmation of species of this isolate. Isoenzyme profile of this isolate was compatible with *L. infantum* MHOM/TN/80/IPT1 strain using 4 enzyme systems (MDH, GPI, ME, and SOD). Isoenzyme electrophoresis was not done for *Crithidia* isolates (isolates No. 2 and 4) due to fund restriction and with respect to their lack of clinical relevancy. It is noteworthy that blastocrithidia form of *Crithidia* was seen in microscopical examination of Geimsa stained slides of the *Crithidia* isolate (isolate No. 2) whereas no promastigote form of *Leishmania* was observed in the slides. In addition, intravenous injection of this isolate into golden hamster did not resulted in parasite growth after 6 months.

Discussion {#S0011}
==========

Feasibility of ITS1 sequencing method {#S20012}
-------------------------------------

Species verification is necessary for isolates of uncertain identity. Isoenzyme electrophoresis is still the gold standard for this purpose ([@CIT0010]). This technique has many limitations: it is demanding, laborious, time consuming, requires bulk cultivation of parasites and only specialized laboratories has the expertise to perform this method ([@CIT0010], [@CIT0015]). Molecular methods are increasingly becoming more popular for identification of *Leishmania* species ([@CIT0010]). Amplification of ITS1 by PCR followed by restriction analysis of the amplification product or sequencing is a molecular method that has proved to be useful for species identification of *Leishmania* isolates ([@CIT0010], [@CIT0015]--[@CIT0020]). Advantages of ITS1 sequencing, in comparison to isoenzyme electrophoresis, include: 1) ITS1 sequencing does not need mass cultivation of parasite. The amount of parasite needed for this technique is reported to be as little as 0.2 parasites that can be retrieved through microscopic glass slides used for routine diagnosis of the disease in clinics or filter paper that can be used in remote areas like villages ([@CIT0015]). This advantage is especially critical for laboratories lacking cell culture facilities. 2) ITS1 sequencing does not need use of reference *Leishmania* strains, because this method uses the reliable database of reference strains (e.g. GenBank) for the comparison. This advantage is especially important for laboratories with no access to reference strains or no facilities for their storage. These two advantages of this method show the relative ease of performance of ITS1 sequencing in comparison to the traditional isoenzyme electrophoresis. Our data confirms the relative feasibility of the ITS1 sequencing method in comparison to isoenzyme electrophoresis method.

Pitfall of mixing up or contamination of isolates {#S20013}
-------------------------------------------------

Our findings show the possibility of mixing up of *Leishmania* isolates or contamination with other trypanosomatids (e.g. *Crithidia*) in the laboratory. Therefore, verification of *Leishmania* species identity is vital for *Leishmania* researches especially research involving different species of *Leishmania*. We studied ITS1 for confirmation of species of 6 *Leishmania* isolates currently in use in different research laboratories in Iran. The results of ITS1 sequence revealed that species of some isolates were not the assumed species (See [Table 1](#T0001){ref-type="table"}). Isoenzyme electrophoresis confirmed the results of ITS1 sequencing for isolates No. 3 (*L. tropica*) and No. 5 (*L. infantum*). So ITS1 sequence and isoenzyme profile show compatible results. Two isolates (No. 2 and 4) were labeled *L. infantum* while they were *C. fasciculata*. These two *Crithidia* isolates have identical ITS1 sequences. This ITS1 sequence (accession number **[HM004585.1]{.ul}**) is novel and has not been already reported. These *Crithidia* species were stated to be isolated from visceral leishmaniasis patients. *Crithidia* microorganisms are reported to infect exclusively invertebrates and predominantly insects ([@CIT0021]) and we found no report for pathogenicity of this trypanosomatid in humans. The real sources of the *Crithidia* isolates studied in the present study remain to be identified. The *Crithidia* has been reported as a contaminant in another study of different *Leishmania* isolates ([@CIT0022]).

Use of ITS1 sequence for species verification {#S20014}
---------------------------------------------

Verification of *Leishmania* species is needed for isolates of uncertain identity. However, species verification by isoenzyme electrophoresis method is not feasible in many laboratories due to its limitation as discussed above. An important application of our findings is use of ITS1 sequence for verification of *Leishmania* species. As we know this is the first study to apply ITS1 sequencing for verification of species identity of *Leishmania* parasites. A shortcoming of our study is the limited number of isolates studied which was due to limitations in fund and manpower. We propose further studies with larger number of isolates for solid conclusion.

In conclusion, our results documented the possibility of mixing up or contamination of *Leishmania* isolates in the laboratory and confirm the relative feasibility of the ITS1 sequencing in comparison to the isoenzyme electrophoresis for species verification. It is suggested that ITS1 sequencing method, with regard to its high specificity and relative ease of performance, can be used for verification of species of *Leishmania* isolates of uncertain identity.
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